MRD Flow Cytometry (Minimal Residual Disease)
- Sample Type
- Bone Marrow Aspirate
- Fasting
- No
- Unit
- percent
Function
Minimal Residual Disease (MRD) testing via flow cytometry is a highly sensitive method used to detect a very small number of cancer cells that remain in a patient's body during or after treatment. While traditional microscopy might show a 'complete remission,' flow cytometry can look at millions of cells to find 1 malignant cell in 10,000 or 100,000.
Why it is Ordered
MRD is the single most powerful predictor of relapse in blood cancers. It is ordered to:
- Evaluate the effectiveness of chemotherapy or bone marrow transplants.
- Determine if additional 'consolidation' therapy is required.
- Monitor for early signs of cancer recurrence before physical symptoms appear.
Associated Conditions
- Acute Lymphoblastic Leukemia (ALL): MRD status is standard of care for prognosticating ALL.
- Acute Myeloid Leukemia (AML): Used to guide the intensity of post-remission therapy.
- Multiple Myeloma: Achieving MRD-negative status is a key goal for survival.
- Chronic Lymphocytic Leukemia (CLL): Helps in deciding when treatment can be safely paused.
By identifying residual disease at a molecular level, clinicians can personalize treatment plans—escalating therapy for those at high risk of relapse and sparing others from unnecessary toxic treatments.
Check Your Result
Check Your Result
Enter your lab result to see where you stand compared to the standard reference range.
Why Context Matters
A second opinion from a specialized hematopathologist is often warranted because MRD interpretation is highly complex and depends on 'gating' strategies. The quality of the sample (hemodilution of bone marrow with peripheral blood) can lead to false-negative results. Furthermore, different laboratories use different antibody panels, which can affect the sensitivity and accuracy of the detection threshold.
Lab ranges are statistical averages, not biological laws. "Normal" for a 20-year-old male isn't normal for a 60-year-old female.
Related Indicators
Medically Reviewed by Dr. Binoy Babu, MBBS
Board Certified Doctor • 10+ Years Clinical Experience
Dr. Babu is a practicing physician dedicated to empowering patients with clear, actionable medical information. He founded 2opi to bridge the gap between complex lab reports and patient understanding, ensuring everyone has access to a reliable second opinion.
Get Notified When Dr. Babu Is Available